Community hub
Recent from talks
Contribute something
Nothing was collected or created yet.
Benzgalantamine
View on Wikipedia
 | |
| Clinical data | |
|---|---|
| Trade names | Zunveyl |
| Other names | ALPHA-1062 |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a624044 |
| License data | |
| Routes of administration | By mouth |
| Drug class | Cholinesterase inhibitor |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C24H25NO4 |
| Molar mass | 391.467 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Benzgalantamine, sold under the brand name Zunveyl, is a medication used for the treatment of mild to moderate dementia of the Alzheimer's type.[1] It is a cholinesterase inhibitor.[1] Benzgalantamine is a prodrug of galantamine.[1]
The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.[1]
Benzgalantamine was approved for medical use in the United States in July 2024.[1][2][3]
Medical uses
[edit]Benzgalantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type in adults.[1][2]
Side effects
[edit]The most common side effects include nausea, vomiting, diarrhea, dizziness, headache, and decreased appetite.[1]
Society and culture
[edit]Legal status
[edit]Benzgalantamine was approved for medical use in the United States in July 2024.[1][2]
Names
[edit]Benzgalantamine is the international nonproprietary name.[4]
References
[edit]- ^ a b c d e f g h i "Zunveyl- benzgalantamine tablet, delayed release". DailyMed. 8 August 2024. Retrieved 15 August 2024.
- ^ a b c fda.gov
- ^ "Alpha Cognition's Oral Therapy Zunveyl Receives FDA Approval to Treat Alzheimer's Disease" (Press release). Alpha Cognition. 29 July 2024. Archived from the original on 4 August 2024. Retrieved 4 August 2024 – via Business Wire.
- ^ World Health Organization (2022). "International nonproprietary names for pharmaceutical substances (INN): recommended INN: list 88". WHO Drug Information. 36 (3). hdl:10665/363551.
External links
[edit]- "Benzgalantamine (Code C188656)". NCI Thesaurus. Archived from the original on 4 August 2024.
